131 related articles for article (PubMed ID: 38449858)
21. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
[TBL] [Abstract][Full Text] [Related]
22. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
24. Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.
Lu P; Wang Y; Liu X; Wang H; Zhang X; Wang K; Wang Q; Hu R
Med Oncol; 2016 Jul; 33(7):66. PubMed ID: 27236327
[TBL] [Abstract][Full Text] [Related]
25. Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma.
Brkic FF; Stoiber S; Maier T; Gurnhofer E; Kenner L; Heiduschka G; Kadletz-Wanke L
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337176
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
27. Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling.
Tao B; Song Y; Wu Y; Yang X; Peng T; Peng L; Xia K; Xia X; Chen L; Zhong C
Aging (Albany NY); 2021 Feb; 13(4):5284-5296. PubMed ID: 33535177
[TBL] [Abstract][Full Text] [Related]
28. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer.
Wang D; Wu S; He J; Sun L; Zhu H; Zhang Y; Liu S; Duan X; Wang Y; Xu T
J Exp Clin Cancer Res; 2023 Sep; 42(1):222. PubMed ID: 37658376
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
[TBL] [Abstract][Full Text] [Related]
30. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
31. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
Tian W; Zhu W; Jiang J
Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
[TBL] [Abstract][Full Text] [Related]
32. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
33. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
[TBL] [Abstract][Full Text] [Related]
34. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
[TBL] [Abstract][Full Text] [Related]
35. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
36. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
[TBL] [Abstract][Full Text] [Related]
37. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
[TBL] [Abstract][Full Text] [Related]
38. Altering cancer transcriptomes using epigenomic inhibitors.
Gaddis M; Gerrard D; Frietze S; Farnham PJ
Epigenetics Chromatin; 2015; 8():9. PubMed ID: 26191083
[TBL] [Abstract][Full Text] [Related]
39. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.
Ganesh S; Shui X; Craig KP; Park J; Wang W; Brown BD; Abrams MT
Mol Ther; 2018 Nov; 26(11):2567-2579. PubMed ID: 30274786
[TBL] [Abstract][Full Text] [Related]
40. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]